Adaptimmune competitive analysis

Latest publications and patents of Adaptimmune New

Explore the latest publications and patents granted to Adaptimmune, showcasing their recent innovations and technological advancements.

Last updated on: Sep 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Adaptimmune

Oct 2, 2024Lentiviral Transduction MethodsGranted And Under Opposition
Jul 19, 2023Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility ComplexGranted And Under Opposition
Jun 14, 2023T Cell ReceptorsPatent Maintained As Amended
Oct 19, 2022Vectors For Transgene ExpressionPatent Maintained As Amended
Jun 12, 2019Tcr LibrariesRevoked
Feb 13, 2019Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility ComplexRevoked

Explore patent oppositions filed by Adaptimmune against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (Hcc) And Other CancersIMMATICS BIOTECHNOLOGIESJun 25, 2020

Explore Adaptimmune's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 2, 2024Lentiviral Transduction Methods1
Jul 19, 2023Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility Complex3
Jun 14, 2023T Cell Receptors1
Oct 19, 2022Vectors For Transgene Expression1
Jun 12, 2019Tcr Libraries1
Feb 13, 2019Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility Complex3

Latest PTAB cases involving Adaptimmune

Discover the latest PTAB cases involving Adaptimmune, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Adaptimmune with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ADAPTIMMUNE110 - - Defensive
DR H ULRICH DORRIES26 - - - Highly Aggressive
GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT8 - - - Highly Aggressive
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBB26 - - - Highly Aggressive